Universal hepatitis B vaccination: the economics of prevention.

di Krahn, M D, Detsky, A S
Pubblicazione 1992

Current and projected annual direct costs of screening asymptomatic men for prostate cancer using prostate-specific antigen

di Krahn, M D, Coombs, A, Levy, I G
Pubblicazione 1999

Prostate cancer: 2. Natural history

di Nam, R K, Jewett, M A, Krahn, M D
Pubblicazione 1998

Prostate cancer: 12. The economic burden

di Grover, S A, Zowall, H, Coupal, L, Krahn, M D
Pubblicazione 1999

Direct and indirect costs of asthma in Canada, 1990.

di Krahn, M D, Berka, C, Langlois, P, Detsky, A S
Pubblicazione 1996

Direct health-care costs attributed to hip fractures among seniors: a matched cohort study

di Nikitovic, M., Wodchis, W. P., Krahn, M. D., Cadarette, S. M.
Pubblicazione 2012

Health care costs for prostate cancer patients receiving androgen deprivation therapy: treatment and adverse events

di Krahn, M.D., Bremner, K.E., Luo, J., Alibhai, S.M.H.
Pubblicazione 2014

A160 ESTIMATION OF FIBROSIS PROGRESSION RATES FOR CHRONIC HEPATITIS C: UPDATED META-ANALYSIS AND META-REGRESSION

di Erman, A, Hansen, T, Bielecki, J M, Feld, J, Krahn, M D, Thein, R
Pubblicato in J Can Assoc Gastroenterol (2018)

Direct costs of coronary artery bypass grafting in patients aged 65 years or more and those under age 65

di Naglie, G, Tansey, C, Krahn, M D, O'Rourke, K, Detsky, A S, Bolley, H
Pubblicazione 1999

Long-term health care costs for prostate cancer patients on androgen deprivation therapy

di Krahn, M.D., Bremner, K.E., Luo, J., Tomlinson, G., Alibhai, S.M.H.
Pubblicato in Curr Oncol (2016)

Population-based trends in systemic therapy use and cost for cancer patients in the last year of life

di Pataky, R.E., Cheung, W.Y., de Oliveira, C., Bremner, K.E., Chan, K.K.W., Hoch, J.S., Krahn, M.D., Peacock, S.J.
Pubblicato in Curr Oncol (2016)